Kasinathan
Chinnaswamy Kasinathan, Holmdel, NJ US
Patent application number | Description | Published |
---|---|---|
20150087591 | Novel Composition for Extracorporeal Reduction of Beta-Amyloids and Process for Producing Thereof - The present invention provides a safe, reliable, and economical process for preparing an improved dialysis fluid formulation effective for extracorporeal treatment, through a blood filtration process, of a Beta-Amyloid associated pathological condition in a subject, said process comprises preparing a composition comprising KLVFF peptide, or a variant thereof, as the capturing and binding agent, and a carrier therefor, and mixing said composition with a dialysate solution. The process utilizes a compact, inexpensive, and simple standard dialysis machine that extracorporeally removes Beta-Amyloids without allowing escape of the Beta-Amyloids back into a subject's body, without having to intricately evaluate the performance and characteristics of a dialysis membrane, and without putting the health condition of the subject at risk. | 03-26-2015 |
Ganasan Kasinathan, Cardiff GB
Patent application number | Description | Published |
---|---|---|
20080300216 | Dutpase Inhibitors - Deoxyuridine derivatives of Formula (I′); where A is O, S or CH | 12-04-2008 |
20080312183 | Dutpase Inhibitors - Deoxyuridine derivatives of the formula (I) where R | 12-18-2008 |
20110021459 | DUTPASE INHIBITORS - Deoxyuridine derivatives of the formula | 01-27-2011 |
Ganasan Kasinathan, Gwent GB
Patent application number | Description | Published |
---|---|---|
20100075924 | DUTPASE INHIBITORS - Deoxyuridine derivatives of the formula | 03-25-2010 |
Poothappillai Kasinathan, Sioux Falls, SD US
Patent application number | Description | Published |
---|---|---|
20090222935 | Transgenic animals and uses thereof - In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein. | 09-03-2009 |
20110231943 | TRANSGENIC ANIMALS AND USES THEREOF - In general, the invention features genetically modified non-human mammals (e.g., bovines and other ungulates), and methods of making these mammals. In particular, the invention features transgenic ungulates having reduced levels of endogenous IgM heavy chain and/or prion protein. | 09-22-2011 |
Poothappillai K. Kasinathan, Brandon, SD US
Patent application number | Description | Published |
---|---|---|
20150247197 | METHODS FOR GENERATING GENETICALLY SUPERIOR ANIMALS - Genetic tests, such as whole genome analysis (WGA), have been employed to identify genetically superior embryos. The disclosed methods extend in vitro culture time of embryos while awaiting results of genetic tests being performed on a portion of the same embryos. The disclosed methods also help expand the number of cells in each embryo before implantation in the recipient. | 09-03-2015 |